Fattouma Bourguiba University Hospital
Monastir, 5000, Tunisia
NCT Number: NCT07112625
This randomized controlled trial evaluates the impact of therapeutic education, with or without personalized coaching, on clinical and biological outcomes in patients with type 2 diabetes during Ramadan fasting. Participants were randomly assigned to three groups: Control (usual care), Education Only, and Education plus Coaching. All received a 30-minute pre-Ramadan education session; the Education plus Coaching group also had follow-up telephone consultations. Outcomes included HbA1c, fasting blood glucose, cholesterol, BMI, and blood pressure measured before and after Ramadan. The study aims to assess whether structured education and ongoing coaching help patients fast safely and maintain better metabolic control.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Monastir, 5000, Tunisia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Type 2 diabetic patients taking oral treatment who intended to fast during Ramadan and agreed to participate in the study.
Exclusion criteria
education associated to coaching
education without coaching
Time frame: From enrollment (two weeks before ramadan219) to two weeks after ramadan 2019
the level of HbA1c after ramadan
Time frame: 6 to 8 weeks
University of Monastir
Other
Impact of Therapeutic Education for Type 2 Diabetic Patients During Ramadan. : A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718880
Chronic Disease, Diabete Mellitus
Lahore, Pakistan
View Trial DetailsNCT07710898
Diabete Mellitus, Diabetes Mellitus
Lahore, Pakistan
View Trial DetailsNCT07688824
Cardiovascular Diseases, Diabete Mellitus
Irbid, Irbid Governorate, Jordan
View Trial DetailsNCT07676838
Cholesterol, Diabete Mellitus
Kocaeli, DARICA, Turkey (Türkiye)
View Trial Details